Breathe eCig Corp. announced that the company is in the process of establishing two distinct, wholly owned subsidiaries. One subsidiary will focus on developing the company's current and future intellectual property and the other will focus on building specified medical devices based on the company's proprietary technologies.

The formation of these two subsidiaries represents incremental new operating businesses and diversification, as the company's focus remains on the E-Cigarette (ECig) space. As soon as the formation of these two wholly owned subsidiaries is complete, the company will notify shareholders through a press release. In addition, the formation of these two wholly owned subsidiaries provides a platform for the company to create potential joint venture partnerships with large pharmaceutical and life sciences companies, as well as foundations and government health care agencies across the globe.